Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
19
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Davis Jefferson E | Chief Business Officer | 4 | $0 | $0 | 2023-11-17 |
| Schelling Chris | President and Chief Executive | 8 | $1.50M | $0 | 2023-11-17 |
| PALMIN HARRY S | Chief Opp. and Financial Offr | 8 | $0 | $0 | 2023-11-17 |
| Joseph Donald | See Remarks | 8 | $50.0K | $0 | 2023-11-17 |
| DUNN JOHN MICHAEL | Director | 10 | $75.0K | $0 | 2023-11-17 |
| ASELAGE STEVE | Director | 15 | $720.7K | $0 | 2023-11-17 |
| Hayden Tanya | Chief Operating Officer | 2 | $0 | $0 | 2023-03-14 |
| Quartel Adrian W | Chief Medical Officer | 2 | $0 | $0 | 2023-03-14 |
| Paul Bernard H | Chief People Officer | 2 | $0 | $0 | 2023-03-14 |
| Klopp John Michael | Chief Technology Officer | 4 | $0 | $0 | 2023-03-14 |
| Amello Jason | Director | 6 | $0 | $0 | 2023-03-14 |
| GRIFFIN MICHELLE RENEE | Director | 6 | $0 | $0 | 2023-03-14 |
| Seibt Matthew | Chief Commercial Officer | 3 | $0 | $0 | 2022-01-14 |
| Andrews William T. | Chief Medical Officer | 5 | $0 | $0 | 2020-03-02 |
| Jutt-Eghbali Salma | Chief Commercial Officer | 1 | $0 | $0 | 2018-12-04 |
| Beeby Reshentha | 10% Owner | 1 | $4.95M | $0 | 2018-08-01 |
| Leatt Gary | 10% Owner | 3 | $4.00M | $0 | 2017-12-12 |
| Steiner Robert D | Chief Medical Officer | 1 | $0 | $0 | 2017-09-19 |
| TVM Life Science Ventures VII L.P. | Director, 10% Owner | 3 | $0 | $0 | 2017-09-19 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Davis Jefferson E | CHIEF BUSINESS OFFICER | D To issuer | 2023-11-17 | 2023-11-20 | 71,645 | — | $0 | 0 | SEC↗ |
| PALMIN HARRY S | CHIEF FINANCIAL OFFICER | D To issuer | 2023-11-17 | 2023-11-20 | 125,000 | — | $0 | 0 | SEC↗ |
| Schelling Chris | PRESIDENT AND CEO | D To issuer | 2023-11-17 | 2023-11-20 | 2,712,529 | — | $0 | 0 | SEC↗ |
| Joseph Donald | See Remarks | D To issuer | 2023-11-17 | 2023-11-20 | 14,285 | — | $0 | 0 | SEC↗ |
| DUNN JOHN MICHAEL | Director | D To issuer | 2023-11-17 | 2023-11-20 | 27,380 | — | $0 | 0 | SEC↗ |
| ASELAGE STEVE | Director | D To issuer | 2023-11-17 | 2023-11-20 | 483,741 | — | $0 | 0 | SEC↗ |
| Amello Jason | Director | A Award deriv | 2023-03-14 | 2023-03-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ASELAGE STEVE | Director | A Award deriv | 2023-03-14 | 2023-03-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Davis Jefferson E | Chief Business Officer | A Award deriv | 2023-03-14 | 2023-03-16 | 30,000 | — | $0 | 30,000 | SEC↗ |
| DUNN JOHN MICHAEL | Director | A Award deriv | 2023-03-14 | 2023-03-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| GRIFFIN MICHELLE RENEE | Director | A Award deriv | 2023-03-14 | 2023-03-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Hayden Tanya | Chief Operating Officer | A Award deriv | 2023-03-14 | 2023-03-16 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Joseph Donald | Chief Legal Officer and Secy | A Award deriv | 2023-03-14 | 2023-03-16 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Klopp John Michael | Chief Technical Officer | A Award deriv | 2023-03-14 | 2023-03-16 | 30,000 | — | $0 | 30,000 | SEC↗ |
| PALMIN HARRY S | Chief Financial Officer | A Award deriv | 2023-03-14 | 2023-03-16 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Paul Bernard H | Chief People Officer | A Award deriv | 2023-03-14 | 2023-03-16 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Quartel Adrian W | Chief Medical Officer | A Award deriv | 2023-03-14 | 2023-03-16 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ASELAGE STEVE | Director | P Buy | 2022-11-29 | 2022-12-01 | 409,836 | $1.22 | $500.0K | 483,741 | SEC↗ |
| Schelling Chris | President & CEO | P Buy | 2022-11-29 | 2022-12-01 | 819,672 | $1.22 | $1000.0K | 2,712,529 | SEC↗ |
| Hayden Tanya | Chief Operating Officer | A Award deriv | 2022-06-19 | 2022-06-22 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Quartel Adrian W | Chief Medical Officer | A Award deriv | 2022-02-21 | 2022-02-23 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Amello Jason | Director | A Award deriv | 2022-01-14 | 2022-01-19 | 18,500 | — | $0 | 18,500 | SEC↗ |
| ASELAGE STEVE | Director | A Award deriv | 2022-01-14 | 2022-01-19 | 18,500 | — | $0 | 18,500 | SEC↗ |
| Davis Jefferson E | Chief Business Officer | A Award deriv | 2022-01-14 | 2022-01-19 | 25,000 | — | $0 | 25,000 | SEC↗ |
| DUNN JOHN MICHAEL | Director | A Award deriv | 2022-01-14 | 2022-01-19 | 18,500 | — | $0 | 18,500 | SEC↗ |
| GRIFFIN MICHELLE RENEE | Director | A Award deriv | 2022-01-14 | 2022-01-19 | 18,500 | — | $0 | 18,500 | SEC↗ |
| Joseph Donald | Chief Legal Officer and Secy | A Award deriv | 2022-01-14 | 2022-01-19 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Klopp John Michael | Chief Technical Officer | A Award deriv | 2022-01-14 | 2022-01-19 | 25,000 | — | $0 | 25,000 | SEC↗ |
| PALMIN HARRY S | Chief Opp. and Financial Of | A Award deriv | 2022-01-14 | 2022-01-19 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Schelling Chris | President & CEO | A Award deriv | 2022-01-14 | 2022-01-19 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Seibt Matthew | Chief Commercial Officer | A Award deriv | 2022-01-14 | 2022-01-19 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Paul Bernard H | Chief People Officer | A Award deriv | 2022-01-14 | 2022-01-21 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ASELAGE STEVE | Director | P Buy | 2021-12-10 | 2021-12-13 | 7,984 | $2.04 | $16.3K | 73,905 | SEC↗ |
| ASELAGE STEVE | Director | P Buy | 2021-12-09 | 2021-12-13 | 2,016 | $2.15 | $4.3K | 65,921 | SEC↗ |
| Davis Jefferson E | Chief Business Officer | A Award deriv | 2021-02-03 | 2021-02-05 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Amello Jason | Director | A Award deriv | 2021-01-15 | 2021-01-20 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ASELAGE STEVE | Director | A Award deriv | 2021-01-15 | 2021-01-20 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DUNN JOHN MICHAEL | Director | A Award deriv | 2021-01-15 | 2021-01-20 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GRIFFIN MICHELLE RENEE | Director | A Award deriv | 2021-01-15 | 2021-01-20 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Joseph Donald | Chief Legal Officer and Secy | A Award deriv | 2021-01-15 | 2021-01-20 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Klopp John Michael | Chief Technical Officer | A Award deriv | 2021-01-15 | 2021-01-20 | 20,000 | — | $0 | 20,000 | SEC↗ |
| PALMIN HARRY S | Chief Opp. and Financial Of | A Award deriv | 2021-01-15 | 2021-01-20 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Schelling Chris | President & CEO | A Award deriv | 2021-01-15 | 2021-01-20 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Seibt Matthew | Chief Commercial Officer | A Award deriv | 2021-01-15 | 2021-01-20 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Schelling Chris | President & CEO | P Buy | 2020-07-24 | 2020-07-28 | 142,857 | $3.50 | $500.0K | 1,892,857 | SEC↗ |
| Joseph Donald | Chief Legal Officer and Secy | P Buy | 2020-07-24 | 2020-07-28 | 14,285 | $3.50 | $50.0K | 14,285 | SEC↗ |
| DUNN JOHN MICHAEL | Director | P Buy | 2020-07-24 | 2020-07-28 | 21,428 | $3.50 | $75.0K | 27,380 | SEC↗ |
| ASELAGE STEVE | Director | P Buy | 2020-07-24 | 2020-07-28 | 45,000 | $3.50 | $157.5K | 63,905 | SEC↗ |
| Andrews William T. | Chief Medical Officer | F Tax w/h | 2020-03-02 | 2020-03-04 | 3,142 | $3.28 | $10.3K | 5,858 | SEC↗ |
| Amello Jason | Director | A Award deriv | 2020-01-02 | 2020-01-03 | 9,000 | — | $0 | 9,000 | SEC↗ |
| ASELAGE STEVE | Director | A Award deriv | 2020-01-02 | 2020-01-03 | 9,000 | — | $0 | 9,000 | SEC↗ |
| DUNN JOHN MICHAEL | Director | A Award deriv | 2020-01-02 | 2020-01-03 | 9,000 | — | $0 | 9,000 | SEC↗ |
| GRIFFIN MICHELLE RENEE | Director | A Award deriv | 2020-01-02 | 2020-01-03 | 9,000 | — | $0 | 9,000 | SEC↗ |
| Seibt Matthew | Chief Commercial Officer | A Award deriv | 2019-09-18 | 2019-09-23 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Andrews William T. | Chief Medical Officer | A Award deriv | 2019-09-18 | 2019-09-23 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Joseph Donald | Chief Legal Officer and Secy | A Award deriv | 2019-09-18 | 2019-09-23 | 40,000 | — | $0 | 40,000 | SEC↗ |
| PALMIN HARRY S | Chief Opp. and Financial Of | A Award deriv | 2019-09-18 | 2019-09-23 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Klopp John Michael | Chief Technology Officer | A Award deriv | 2019-09-18 | 2019-09-25 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ASELAGE STEVE | Director | P Buy | 2019-07-03 | 2019-07-05 | 5,000 | $3.72 | $18.6K | 18,905 | SEC↗ |
| Andrews William T. | Chief Medical Officer | A Award | 2019-03-01 | 2019-03-05 | 9,000 | — | $0 | 9,000 | SEC↗ |
| Amello Jason | Director | A Award deriv | 2019-02-01 | 2019-02-05 | 6,000 | — | $0 | 6,000 | SEC↗ |
| Andrews William T. | Chief Medical Officer | A Award deriv | 2019-02-01 | 2019-02-05 | 27,000 | — | $0 | 27,000 | SEC↗ |
| ASELAGE STEVE | Director | A Award deriv | 2019-02-01 | 2019-02-05 | 6,000 | — | $0 | 6,000 | SEC↗ |
| DUNN JOHN MICHAEL | Director | A Award deriv | 2019-02-01 | 2019-02-05 | 6,000 | — | $0 | 6,000 | SEC↗ |
| GRIFFIN MICHELLE RENEE | Director | A Award deriv | 2019-02-01 | 2019-02-05 | 6,000 | — | $0 | 6,000 | SEC↗ |
| Joseph Donald | Chief Legal Officer and Secy | A Award deriv | 2019-02-01 | 2019-02-05 | 27,000 | — | $0 | 27,000 | SEC↗ |
| PALMIN HARRY S | Chief Opp. and Financial Of | A Award deriv | 2019-02-01 | 2019-02-05 | 27,000 | — | $0 | 27,000 | SEC↗ |
| Schelling Chris | President and Chief Executiv | A Award deriv | 2019-02-01 | 2019-02-05 | 72,500 | — | $0 | 72,500 | SEC↗ |
| Jutt-Eghbali Salma | Chief Commercial Officer | A Award deriv | 2018-12-04 | 2018-12-06 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Beeby Reshentha | 10% Owner | P Buy | 2018-08-01 | 2018-08-22 | 275,000 | $18.00 | $4.95M | 1,697,709 | SEC↗ |
| Joseph Donald | Chief Legal Officer and Secy | A Award deriv | 2018-04-20 | 2018-04-23 | 60,000 | — | $0 | 60,000 | SEC↗ |
| ASELAGE STEVE | Director | P Buy | 2017-12-14 | 2017-12-18 | 2,000 | $12.00 | $24.0K | 13,905 | SEC↗ |
| Leatt Gary | 10% Owner | P Buy | 2017-12-12 | 2018-01-12 | 21,271 | $12.00 | $255.3K | 248,756 | SEC↗ |
| Leatt Gary | 10% Owner | P Buy | 2017-12-12 | 2018-01-12 | 250,000 | $12.00 | $3.00M | 1,422,709 | SEC↗ |
| Leatt Gary | 10% Owner | P Buy | 2017-12-12 | 2018-01-12 | 62,062 | $12.00 | $744.7K | 725,844 | SEC↗ |
| Schelling Chris | President and CEO | A Award deriv | 2017-10-04 | 2017-10-06 | 46,000 | — | $0 | 46,000 | SEC↗ |
| PALMIN HARRY S | Chief Financial Officer | A Award deriv | 2017-10-04 | 2017-10-06 | 67,600 | — | $0 | 67,600 | SEC↗ |
| Amello Jason | Director | A Award deriv | 2017-10-04 | 2017-10-06 | 9,000 | — | $0 | 9,000 | SEC↗ |
| DUNN JOHN MICHAEL | Director | A Award deriv | 2017-10-04 | 2017-10-06 | 6,000 | — | $0 | 6,000 | SEC↗ |
| GRIFFIN MICHELLE RENEE | Director | A Award deriv | 2017-10-04 | 2017-10-06 | 9,000 | — | $0 | 9,000 | SEC↗ |
| ASELAGE STEVE | Director | A Award deriv | 2017-10-04 | 2017-10-06 | 6,000 | — | $0 | 6,000 | SEC↗ |
| Andrews William T. | Chief Medical Officer | A Award deriv | 2017-10-04 | 2017-10-06 | 100,000 | — | $0 | 100,000 | SEC↗ |
| DUNN JOHN MICHAEL | Director | J Other deriv | 2017-09-19 | 2017-09-21 | 16,000 | — | $0 | 16,000 | SEC↗ |
| ASELAGE STEVE | Director | J Other deriv | 2017-09-19 | 2017-09-21 | 21,000 | — | $0 | 21,000 | SEC↗ |
| Steiner Robert D | Chief Medical Officer | J Other deriv | 2017-09-19 | 2017-09-21 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Schelling Chris | President and CEO | J Other | 2017-09-19 | 2017-09-21 | 1,750,000 | — | $0 | 1,750,000 | SEC↗ |
| DUNN JOHN MICHAEL | Director | J Other | 2017-09-19 | 2017-09-21 | 5,952 | — | $0 | 5,952 | SEC↗ |
| ASELAGE STEVE | Director | J Other | 2017-09-19 | 2017-09-21 | 11,905 | — | $0 | 11,905 | SEC↗ |
| PALMIN HARRY S | Chief Financial Officer | J Other | 2017-09-19 | 2017-09-21 | 125,000 | — | $0 | 125,000 | SEC↗ |
| TVM Life Science Ventures VII | Director, 10% Owner | J Other | 2017-09-19 | 2017-09-27 | 227,485 | — | $0 | 227,485 | SEC↗ |
| TVM Life Science Ventures VII | Director, 10% Owner | J Other | 2017-09-19 | 2017-09-27 | 1,172,709 | — | $0 | 1,172,709 | SEC↗ |
| TVM Life Science Ventures VII | Director, 10% Owner | J Other | 2017-09-19 | 2017-09-27 | 663,782 | — | $0 | 663,782 | SEC↗ |